|
Volumn 39, Issue 5-6, 2000, Pages 573-582
|
Increased cytotoxicity against B-chronic lymphocytic leukemia by cellular manipulations: Potentials for therapeutic use
a a a a |
Author keywords
Antisense therapy; B chronic lymphocytic leukemia; Bcl 2; Cytotoxicity; Dendritic cells; Fludarabine
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGONUCLEOTIDE;
B7 ANTIGEN;
CD1 ANTIGEN;
CD3 ANTIGEN;
CD4 ANTIGEN;
CD83 ANTIGEN;
CYTOKINE;
FAS ANTIGEN;
FLUDARABINE;
INTERLEUKIN 2;
PROTEIN BCL 2;
ACCESSORY CELL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
B CELL LEUKEMIA;
CANCER IMMUNOTHERAPY;
CELL ACTIVATION;
CELL IMMORTALIZATION;
CELL MEDIATED CYTOTOXICITY;
CELL POPULATION;
CELL STRAIN K 562;
CHRONIC LYMPHATIC LEUKEMIA;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOLOGY;
CYTOLYSIS;
CYTOTOXICITY;
DENDRITIC CELL;
DOWN REGULATION;
EFFECTOR CELL;
GENE EXPRESSION;
HUMAN;
HUMAN CELL;
IMMUNOCOMPETENT CELL;
IMMUNOPATHOLOGY;
IN VITRO STUDY;
LEUKEMIA CELL LINE;
LYMPHOCYTE ACTIVATION;
LYMPHOKINE ACTIVATED KILLER CELL;
NATURAL KILLER CELL;
NATURAL KILLER CELL MEDIATED CYTOTOXICITY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
STANDARD;
TARGET CELL;
UMBILICAL CORD BLOOD;
|
EID: 0034489227
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.3109/10428190009113387 Document Type: Article |
Times cited : (7)
|
References (29)
|